Skip to content

Home Pulse Oximeter Use in Patients With COVID-19

Utilizing Home Pulse Oximetry for Patients With COVID-19 To Monitor Disease Progression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04373161
Enrollment
209
Registered
2020-05-04
Start date
2020-03-20
Completion date
2020-04-22
Last updated
2020-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID, COVID-19, Sars-CoV2

Keywords

Oximetry, Oximeter, COVID-19

Brief summary

The purpose of this study is to investigate the use of home pulse oximetry monitoring in patients with COVID-19 to trend disease progression and identify need for hospitalization.

Detailed description

This protocol studies patients with suspected non-severe Corona Virus Disease (COVID-19) being discharged to home from an emergency department (ED) or outpatient testing center. Patients will be provided a portable fingertip home pulse oximeter that measures peripheral oxygen saturation (SpO2). Patients will be instructed to check their resting home oxygen saturation three times per day and record these findings. They will be instructed to return to the emergency room for sustained oxygen saturation below 92% or if their symptoms are worsening and they feel they need medical attention. Patients will be called once daily by the research team to collect data in real time. Patients will be monitored for seven days, and at the end of the seven day period, they will return the pulse oximeter as well as a spreadsheet of their home oximetry readings. The purpose is to see if home pulse oximetry identifies disease progression and need for hospitalization in patients with COVID-19. Additionally, there will be analysis of trends in home oximetry readings wand predictors of morbidity and mortality.

Interventions

Patients to check their home oxygen saturation three times daily and return to the ED for sustain oxygen \<92% or for worsening symptoms.

Sponsors

Swedish Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with suspected COVID-19 as defined by the World Health Organization * Age \> 18

Exclusion criteria

* Pregnancy * Prisoners * Lack of decision making capacity or cannot provide consent * Patients being admitted to the hospital * Patients on home oxygen * Patients being discharged to a skilled nursing facility

Design outcomes

Primary

MeasureTime frameDescription
Hospitalization in COVID-19 patients with low home SpO27 days after enrollmentThe primary outcome is the relative risk of hospitalization in COVID-19 patients with resting home pulse oximeter SpO2 below 92%.

Secondary

MeasureTime frameDescription
Timing of SpO2 <92%7 days after enrollmentThis will evaluate if there is a correlation between the time of day with SpO2 readings below 92 percent in patients with suspected COVID-19.
Home pulse oximeter use effect on subsequent ED visits7 days after enrollmentThe goal of this outcome is to see if patients enrolled in the study are reassured by use of home pulse oximeter monitoring and if this device prevents subsequent ED visits by patients
Reason for return to the Emergency Department7 days after enrollmentTo see if patients who return to the ED and end up hospitalized did so for incidental finding of low home pulse oximetry or if it was for worsening symptoms
Trend in resting home pulse oximetry readings7 days after enrollmentThe purpose of this outcome is to determine if home pulse oximetry readings abruptly drop, gradually decline, or stay level in patients with COVID-19
Hospitalization outcome - mortalityUp to 21 days after enrollmentThe study will assess mortality defined as death after admission to the hospital in patients with SpO2 \<92%
Median Length of StayUp to 21 days after enrollmentThe study will measure median length of stay in patients with COVID-19 that are hospitalized on subsequent return to the ED.
Hospitalization outcome - morbidityUp to 21 days after enrollmentThe study will assess development of morbidity defined as intensive care unit admission, acute respiratory distress syndrome, and/or septic shock in patients with SpO2 \<92%

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026